Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| NBIX | Boyer David W. | Chief Corp. Affairs Officer | 09/14/2026 | Verkauf | 157.45 | 826 | 130,051 | Form 4 |
| NBIX | Abernethy Matt | Chief Financial Officer | 09/14/2026 | Verkauf | 157.20 | 2,311 | 363,285 | Form 4 |
| NBIX | Delaet Ingrid | Chief Regulatory Officer | 09/11/2026 | Steuer-Abgabe | 156.22 | 2,419 | 377,896 | Form 4 |
| NBIX | Delaet Ingrid | Chief Regulatory Officer | 09/11/2026 | Zuteilung | — | 4,483 | — | Form 4 |
| NBIX | Boyer David W. | Chief Corp. Affairs Officer | 09/11/2026 | Steuer-Abgabe | 156.22 | 1,936 | 302,442 | Form 4 |
| NBIX | Boyer David W. | Chief Corp. Affairs Officer | 09/11/2026 | Zuteilung | — | 3,587 | — | Form 4 |
| NBIX | Onyia Jude | Chief Scientific Officer | 09/11/2026 | Steuer-Abgabe | 156.22 | 1,936 | 302,442 | Form 4 |
| NBIX | Onyia Jude | Chief Scientific Officer | 09/11/2026 | Zuteilung | — | 3,587 | — | Form 4 |
| NBIX | Keswani Sanjay Chandru | Chief Medical Officer | 09/11/2026 | Steuer-Abgabe | 156.22 | 2,112 | 329,937 | Form 4 |
| NBIX | Keswani Sanjay Chandru | Chief Medical Officer | 09/11/2026 | Zuteilung | — | 3,914 | — | Form 4 |
| NBIX | Cooke Julie | Chief Human Resources Officer | 09/11/2026 | Steuer-Abgabe | 156.22 | 1,936 | 302,442 | Form 4 |
| NBIX | Cooke Julie | Chief Human Resources Officer | 09/11/2026 | Zuteilung | — | 3,587 | — | Form 4 |
| NBIX | Abernethy Matt | Chief Financial Officer | 09/11/2026 | Steuer-Abgabe | 156.22 | 2,709 | 423,200 | Form 4 |
| NBIX | Abernethy Matt | Chief Financial Officer | 09/11/2026 | Zuteilung | — | 5,020 | — | Form 4 |
| NBIX | Benevich Eric | Chief Commercial Officer | 09/11/2026 | Steuer-Abgabe | 156.22 | 3,386 | 528,961 | Form 4 |
| NBIX | Benevich Eric | Chief Commercial Officer | 09/11/2026 | Zuteilung | — | 6,275 | — | Form 4 |
| NBIX | Gano Kyle | Chief Executive Officer | 09/11/2026 | Steuer-Abgabe | 156.22 | 994 | 155,283 | Form 4 |
| NBIX | Gano Kyle | Chief Executive Officer | 09/11/2026 | Zuteilung | — | 1,842 | — | Form 4 |
| NBIX | Gano Kyle | Chief Executive Officer | 09/11/2026 | Steuer-Abgabe | 156.22 | 3,386 | 528,961 | Form 4 |
| NBIX | Gano Kyle | Chief Executive Officer | 09/11/2026 | Zuteilung | — | 6,275 | — | Form 4 |
| NBIX | Lippoldt Darin | Chief Legal Officer | 09/11/2026 | Steuer-Abgabe | 156.22 | 2,419 | 377,896 | Form 4 |
| NBIX | Lippoldt Darin | Chief Legal Officer | 09/11/2026 | Zuteilung | — | 4,483 | — | Form 4 |
| NBIX | Gorman Kevin Charles | Director | 09/11/2026 | Steuer-Abgabe | 156.22 | 7,839 | 1,224,609 | Form 4 |
| NBIX | Gorman Kevin Charles | Director | 09/11/2026 | Zuteilung | — | 14,343 | — | Form 4 |
| NBIX | Benevich Eric | Chief Commercial Officer | 09/09/2026 | Verkauf | 154.61 | 2,154 | 333,030 | Form 4 |
| NBIX | Benevich Eric | Chief Commercial Officer | 09/09/2026 | Optionsausübung | 43.24 | 3,194 | 138,109 | Form 4 |
| NBIX | Sherwin Stephen A | Director | 09/02/2026 | Schenkung | — | 1,000 | — | Form 4 |
| NBIX | Onyia Jude | Chief Scientific Officer | 08/04/2026 | Schenkung | — | 2,409 | — | Form 4 |
| NBIX | Norwalk Leslie V | Director | 07/29/2026 | Optionsausübung | 139.43 | 842 | 117,400 | Form 4 |
| NBIX | Norwalk Leslie V | Director | 07/28/2026 | Verkauf | 182.01 | 1,250 | 227,508 | Form 4 |
| NBIX | Delaet Ingrid | Chief Regulatory Officer | 07/10/2026 | Verkauf | 181.02 | 4,367 | 790,514 | Form 4 |
| NBIX | Delaet Ingrid | Chief Regulatory Officer | 07/10/2026 | Optionsausübung | 106.02 | 4,367 | 462,989 | Form 4 |
| NBIX | Lippoldt Darin | Chief Legal Officer | 07/09/2026 | Verkauf | 179.60 | 10,000 | 1,796,014 | Form 4 |
| NBIX | Lippoldt Darin | Chief Legal Officer | 07/09/2026 | Optionsausübung | 81.49 | 10,000 | 814,900 | Form 4 |
| NBIX | Delaet Ingrid | Chief Regulatory Officer | 07/09/2026 | Verkauf | 178.72 | 8,433 | 1,507,135 | Form 4 |
| NBIX | Delaet Ingrid | Chief Regulatory Officer | 07/09/2026 | Optionsausübung | 103.52 | 8,433 | 872,984 | Form 4 |
| NBIX | Delaet Ingrid | Chief Regulatory Officer | 07/08/2026 | Verkauf | 178.54 | 2,737 | 488,672 | Form 4 |
| NBIX | Delaet Ingrid | Chief Regulatory Officer | 07/08/2026 | Optionsausübung | 103.52 | 2,737 | 283,334 | Form 4 |
| NBIX | Delaet Ingrid | Chief Regulatory Officer | 07/07/2026 | Verkauf | 178.57 | 3,401 | 607,305 | Form 4 |
| NBIX | Delaet Ingrid | Chief Regulatory Officer | 07/07/2026 | Optionsausübung | 103.52 | 3,401 | 352,072 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).